{"id":"https://openalex.org/W2591284091","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3570","title":"Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome.","display_name":"Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of KRAS and BRAF biomarker status with treatment outcome.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2591284091","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3570","mag":"2591284091"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.3570","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3570","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.3570","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2591284091"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090645179","display_name":"Eric Van Cutsem","orcid":"https://orcid.org/0000-0002-6372-1230","observed_orcids":["https://orcid.org/0000-0002-6372-1230"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Van Cutsem","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112189754","display_name":"Istv\u00e1n L\u00e1ng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Lang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019710731","display_name":"Gunnar Folprecht","orcid":"https://orcid.org/0000-0002-9321-9911","observed_orcids":["https://orcid.org/0000-0002-9321-9911"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Folprecht","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036354703","display_name":"Marek P. Nowacki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Nowacki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012446712","display_name":"Carlo Antonio Barone","orcid":"https://orcid.org/0000-0002-2375-2016","observed_orcids":["https://orcid.org/0000-0002-2375-2016"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Barone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060115768","display_name":"Igor B. Shchepotin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Shchepotin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028687949","display_name":"Joan Maurel","orcid":"https://orcid.org/0000-0002-9413-5592","observed_orcids":["https://orcid.org/0000-0002-9413-5592"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Maurel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056345420","display_name":"David Cunningham","orcid":"https://orcid.org/0000-0001-5158-1069","observed_orcids":["https://orcid.org/0000-0001-5158-1069"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Cunningham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101935942","display_name":"\u0130. \u00c7elik","orcid":"https://orcid.org/0000-0003-3709-2511","observed_orcids":["https://orcid.org/0000-0003-3709-2511"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Celik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112022960","display_name":"Claus Henning K\u00f6hne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Kohne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":71,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"3570","last_page":"3570"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8859999775886536},{"id":"https://openalex.org/keywords/kras-mutation-status","display_name":"KRAS mutation status","score":0.9409999847412109},{"id":"https://openalex.org/keywords/braf-mutation-status","display_name":"BRAF mutation status","score":0.9890000224113464},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9760000109672546},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/crystal-trial","display_name":"CRYSTAL trial","score":0.8109999895095825},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7879999876022339},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.41600000858306885},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.981346607208252},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9472100734710693},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9216952323913574},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8185526132583618},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.706262469291687},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.6568450927734375},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5980955958366394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5909389853477478},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.531807541847229},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35143452882766724},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.33553749322891235},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3240628242492676},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.3570","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.3570","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.3570","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2231852462","https://openalex.org/W2134142320","https://openalex.org/W2589823065","https://openalex.org/W2395015236","https://openalex.org/W2139168548","https://openalex.org/W2036045525","https://openalex.org/W4250728136","https://openalex.org/W2467230081","https://openalex.org/W2112570485","https://openalex.org/W2057443563"],"abstract_inverted_index":{"3570":[0],"Background:":[1],"The":[2],"phase":[3],"III":[4],"CRYSTAL":[5],"study":[6],"showed":[7],"that":[8],"patients":[9],"(pts)":[10],"with":[11,102,119,130,172],"KRAS":[12,41,92,103,131,161,209,212,217],"wild-type":[13],"(wt)":[14],"tumors":[15],"benefit":[16],"from":[17],"the":[18,83,96,158,192,199],"addition":[19,193],"of":[20,37,139,160,167,194],"cetuximab":[21,115,175,195],"to":[22,70,185,196,206],"FOLFIRI":[23,117,120,177,197,221,225,228,232,234,238],"as":[24,164],"first-line":[25],"treatment":[26,144,168],"for":[27,52,91,191],"metastatic":[28],"colorectal":[29],"cancer":[30],"(mCRC).":[31],"BRAF":[32,43,123,134,179],"is":[33],"a":[34,137,165,187],"downstream":[35],"effector":[36],"KRAS.":[38],"Methods:":[39],"Tumor":[40,122],"and":[42,61,75],"mutation":[44,71,93,135,180],"status":[45,72,124,163,181],"(wt":[46],"or":[47,334,338],"mutant":[48],"[mt])":[49],"was":[50,125,136],"determined":[51],"an":[53],"expanded":[54],"patient":[55],"population":[56],"using":[57],"polymerase":[58],"chain":[59],"reaction":[60],"melting":[62],"curve":[63],"assays.":[64],"Treatment":[65],"arms":[66,145],"were":[67,89,109],"compared":[68,118],"according":[69],"(log":[73],"rank":[74],"Cochran-Mantel-Haenszel":[76],"tests).":[77],"Results:":[78],"Of":[79],"1,198":[80],"pts":[81,101,113,129,171],"in":[82,112,127,142,170],"primary":[84],"analysis":[85,156],"population,":[86],"1,063":[87],"(89%)":[88],"evaluable":[90,126],"status;":[94],"double":[95],"previous":[97],"ascertainment":[98],"rate.":[99],"In":[100],"wt":[104,132,210,214],"tumors,":[105],"all":[106,150],"efficacy":[107,151],"endpoints":[108],"significantly":[110],"improved":[111],"receiving":[114,174],"+":[116,224,231,237],"alone.":[121],"625/666":[128],"tumors.":[133],"marker":[138],"poor":[140],"prognosis":[141],"both":[143],"(see":[146],"Table).":[147],"Conclusions:":[148],"For":[149],"endpoints,":[152],"including":[153],"survival,":[154],"this":[155],"confirms":[157],"value":[159],"mutational":[162],"predictor":[166],"outcome":[169],"mCRC":[173],"plus":[176],"first-line.":[178],"does":[182],"not":[183],"appear":[184],"be":[186,203,207],"strong":[188],"predictive":[189],"biomarker":[190],"but":[198],"sample":[200],"size":[201],"may":[202],"too":[204],"small":[205],"conclusive.":[208],"n=666":[211],"wt/BRAF":[213,218],"n=":[215,226,239],"566":[216],"mt":[219],"n=59":[220],"n=350":[222],"Cetuximab":[223,230,236],"316":[227],"n=289":[229],"n=277":[233],"n=33":[235],"26":[240],"Median":[241,270],"OS":[242],"months":[243],"([95%":[244],"CI)":[245,261,273,289,304,320],"20.0":[246],"(17.4\u201321.7)":[247],"23.5":[248],"(21.2\u201326.3)":[249],"21.6":[250],"(20.0\u201324.9)":[251],"25.1":[252],"(22.5\u201328.7)":[253],"10.3":[254],"(8.4\u201314.9)":[255],"14.1":[256],"(8.5\u201318.5)":[257],"Hazard":[258,286],"ratio":[259,287,318],"(95%":[260,288,303,319],"0.796":[262],"(0.670\u20130.946)":[263],"0.830(0.687\u20131.004)":[264],"0.908(0.507\u20131.624)":[265],"p":[266,296,327],"0.0093":[267],"0.0549":[268],"0.7440":[269],"PFS":[271],"months(95%":[272],"8.4":[274],"(7.4\u20139.2)":[275],"9.9":[276],"(9.0\u201311.3)":[277],"8.8":[278],"(7.6\u20139.4)":[279],"10.9":[280],"(9.4\u201311.8)":[281],"5.6":[282],"(3.5\u20138.1)":[283],"8.0":[284],"(3.6\u20139.1)":[285],"0.696":[290],"(0.558\u20130.867)":[291],"0.679":[292],"(0.533\u20130.864)":[293],"0.934":[294],"(0.425\u20132.056)":[295],"0.0012":[297],"0.0016":[298],"0.8656":[299],"OR":[300],"rate":[301],"(%)":[302],"39.7":[305],"(34.6\u201345.1)":[306],"57.3":[307],"(51.6\u201362.8)":[308],"42.6":[309],"(36.8\u201348.5)":[310],"61.0":[311],"(55.0\u201366.8)":[312],"15.2":[313],"(5.1\u201331.9)":[314],"19.2":[315],"(6.6\u201339.4)":[316],"Odds":[317],"2.0693":[321],"(1.5154\u20132.8258)":[322],"2.1750":[323],"(1.5505\u20133.0511)":[324],"1.0842":[325],"(0.2644\u20134.4456)":[326],"<0.0001":[328,329],"0.9136":[330],"Author":[331],"Disclosure":[332],"Employment":[333],"Leadership":[335],"Position":[336],"Consultant":[337],"Advisory":[339],"Role":[340],"Stock":[341],"Ownership":[342],"Honoraria":[343],"Research":[344],"Funding":[345],"Expert":[346],"Testimony":[347],"Other":[348],"Remuneration":[349],"Merck":[350,352,356,359,364],"KGaA":[351],"KGaA/Merck":[353,357],"Serono":[354],"Amgen,":[355],"Serono,":[358,360,365],"Pfizer,":[361,366],"Roche,":[362],"sanofi-aventis":[363,367]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2591284091","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2017-03-03T00:00:00"}
